Vanguard Fiduciary Trust
HUMA icon

Vanguard Fiduciary Trust’s Humacyte HUMA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$921K Buy
1,181,276
+170,247
+17% +$158K ﹤0.01% 3057
2026
Q1 		$614K Buy
+1,011,029
New +$1.05M ﹤0.01% 3150

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Fiduciary Trust's HUMA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Humacyte (HUMA) stake by 17% in Q2 2026, buying an estimated $158K and bringing the position to 1,181,276 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

Vanguard Fiduciary Trust first reported a position in HUMA in Q1 2026 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,181,276 shares of Humacyte worth $921K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 170,247 Humacyte shares in Q2 2026, an estimated $158K.
  • Humacyte made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3057 holding.
  • Vanguard Fiduciary Trust first reported a position in Humacyte in Q1 2026 and has held it in 2 quarters since.
  • 147 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.